Location History:
- Kato, JP (2017)
- Osaka, JP (2024)
Company Filing History:
3 out of 148 
2 out of 129 
1 out of 13 Years Active: 2017-2025
Title: Kentaro Abe: Innovator in Cancer and Inflammation Research
Introduction
Kentaro Abe is a prominent inventor based in Osaka, Japan, known for his significant contributions to the fields of cancer and inflammation research. With a total of three patents to his name, Abe has developed innovative methods that aim to inhibit the expression of factors promoting cancer and inflammation.
Latest Patents
Abe's latest patents include a method for inhibiting the expression of cancer-promoting factors. This invention provides an expression inhibitor based on the discovery of a new factor influencing the expression level of cancer-promoting factors. It also includes a diagnostic agent and method for cancer diagnosis. Specifically, the invention features an expression inhibitor containing at least one kind of inhibitor selected from the group consisting of RBMS expression inhibitor and RBMS function inhibitor. Additionally, it offers a screening method using the expression or function of RBMS as an indicator, along with an expression cassette useful for the method.
Another notable patent is a method for inhibiting the expression of inflammation-promoting factors. This invention also provides an expression inhibitor based on a newly discovered factor influencing the expression level of inflammation-promoting factors. It includes a diagnostic agent and method for immune diseases, inflammatory diseases, and painful conditions. The expression inhibitor contains at least one kind of inhibitor selected from the group consisting of RBMS2 expression inhibitor and RBMS2 function inhibitor. Furthermore, it features a screening method using the expression or function of RBMS2 as an indicator, along with an expression cassette useful for the method.
Career Highlights
Kentaro Abe has worked with notable organizations such as Nippon Zoki Pharmaceutical Co., Ltd. and Tokyo Medical and Dental University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Abe has collaborated with esteemed colleagues, including Hiroshi Asahara and Tomoki Chiba. These partnerships have played a crucial role in the development of his innovative patents.
Conclusion
Kentaro Abe's work in inhibiting cancer and inflammation-promoting factors showcases his dedication to advancing medical research. His innovative patents and collaborations highlight his significant impact in the field.